{
  "SOBR": {
    "Symbol": "SOBR",
    "AssetType": "Common Stock",
    "Name": "Sobr Safe Inc",
    "Description": "SOBR Safe, Inc. develops non-invasive identity verification and alcohol detection systems. The company is headquartered in Greenwood Village, Colorado.",
    "CIK": "1425627",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "PERIODICALS: PUBLISHING OR PUBLISHING & PRINTING",
    "Address": "885 ARAPAHOE ROAD, BOULDER, CO, US",
    "OfficialSite": "https://sobrsafe.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1032600",
    "EBITDA": "-7435655",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.61",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-51.46",
    "RevenuePerShareTTM": "0.858",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-40.06",
    "ReturnOnAssetsTTM": "-0.891",
    "ReturnOnEquityTTM": "-2.917",
    "RevenueTTM": "183860",
    "GrossProfitTTM": "73820",
    "DilutedEPSTTM": "-51.46",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.272",
    "AnalystTargetPrice": "4.25",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "5.62",
    "PriceToBookRatio": "0.495",
    "EVToRevenue": "6.5",
    "EVToEBITDA": "-3.721",
    "Beta": "-0.097",
    "52WeekHigh": "81.4",
    "52WeekLow": "0.79",
    "50DayMovingAverage": "1.315",
    "200DayMovingAverage": "11.3",
    "SharesOutstanding": "921950",
    "DividendDate": "2020-06-08",
    "ExDividendDate": "None"
  },
  "TLRY": {
    "Symbol": "TLRY",
    "AssetType": "Common Stock",
    "Name": "Tilray Inc",
    "Description": "Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.",
    "CIK": "1731348",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "MEDICINAL CHEMICALS & BOTANICAL PRODUCTS",
    "Address": "1100 MAUGHAN ROAD, NANAIMO, BC, CA",
    "OfficialSite": "https://www.tilray.com",
    "FiscalYearEnd": "May",
    "LatestQuarter": "2024-11-30",
    "MarketCapitalization": "888675000",
    "EBITDA": "31318000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.752",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.3",
    "RevenuePerShareTTM": "1.029",
    "ProfitMargin": "-0.3",
    "OperatingMarginTTM": "-0.153",
    "ReturnOnAssetsTTM": "-0.0145",
    "ReturnOnEquityTTM": "-0.0702",
    "RevenueTTM": "829216000",
    "GrossProfitTTM": "256646000",
    "DilutedEPSTTM": "-0.3",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.089",
    "AnalystTargetPrice": "1.824",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "10",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "1000",
    "PriceToSalesRatioTTM": "1.072",
    "PriceToBookRatio": "0.254",
    "EVToRevenue": "1.211",
    "EVToEBITDA": "-4.841",
    "Beta": "1.986",
    "52WeekHigh": "2.97",
    "52WeekLow": "0.825",
    "50DayMovingAverage": "1.168",
    "200DayMovingAverage": "1.582",
    "SharesOutstanding": "933973000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "RTC": {
    "Symbol": "RTC",
    "AssetType": "Common Stock",
    "Name": "Baijiayun Group Ltd",
    "Description": "Baijiayun Group Ltd engages in the provision of video-centric technology solutions. The company is headquartered in Beijing, China.",
    "CIK": "1381074",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "MANUFACTURING",
    "Industry": "UNSUPPORTED PLASTICS FILM & SHEET",
    "Address": "NO. 387 DONGMING ROAD, WEIFANG, SHANDONG, CHINA",
    "OfficialSite": "https://www.baijiayun.com",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "13704900",
    "EBITDA": "-48347028",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.227",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-4.25",
    "RevenuePerShareTTM": "3.105",
    "ProfitMargin": "-1.369",
    "OperatingMarginTTM": "-1.002",
    "ReturnOnAssetsTTM": "-0.308",
    "ReturnOnEquityTTM": "-1.464",
    "RevenueTTM": "59795000",
    "GrossProfitTTM": "12992300",
    "DilutedEPSTTM": "-4.25",
    "QuarterlyEarningsGrowthYOY": "-0.308",
    "QuarterlyRevenueGrowthYOY": "-0.253",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.229",
    "PriceToBookRatio": "0.542",
    "EVToRevenue": "0.237",
    "EVToEBITDA": "7.42",
    "Beta": "-0.278",
    "52WeekHigh": "9.69",
    "52WeekLow": "0.45",
    "50DayMovingAverage": "2.353",
    "200DayMovingAverage": "5.81",
    "SharesOutstanding": "19659000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GRAB": {
    "Symbol": "GRAB",
    "AssetType": "Common Stock",
    "Name": "Grab Holdings Ltd",
    "Description": "None",
    "CIK": "1855612",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-BUSINESS SERVICES, NEC",
    "Address": "3 MEDIA CLOSE, #01-03/06, SINGAPORE, SINGAPORE",
    "OfficialSite": "https://www.grab.com/sg",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "19918500000",
    "EBITDA": "-7000000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.574",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.03",
    "RevenuePerShareTTM": "0.7",
    "ProfitMargin": "-0.0375",
    "OperatingMarginTTM": "0.0118",
    "ReturnOnAssetsTTM": "-0.0106",
    "ReturnOnEquityTTM": "-0.0247",
    "RevenueTTM": "2797000000",
    "GrossProfitTTM": "1174000000",
    "DilutedEPSTTM": "-0.03",
    "QuarterlyEarningsGrowthYOY": "-0.252",
    "QuarterlyRevenueGrowthYOY": "0.17",
    "AnalystTargetPrice": "5.76",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "18",
    "AnalystRatingHold": "5",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "88.5",
    "PriceToSalesRatioTTM": "7.12",
    "PriceToBookRatio": "3.113",
    "EVToRevenue": "5.24",
    "EVToEBITDA": "92.74",
    "Beta": "0.902",
    "52WeekHigh": "5.72",
    "52WeekLow": "2.98",
    "50DayMovingAverage": "4.82",
    "200DayMovingAverage": "4.035",
    "SharesOutstanding": "3950000000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "NKGN": {
    "Symbol": "NKGN",
    "AssetType": "Common Stock",
    "Name": "NKGen Biotech, Inc. Common Stock",
    "Description": "NKGen Biotech, Inc. is a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. The company is headquartered in Santa Ana, California.",
    "CIK": "1845459",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "1790 HUGHES LANDING BOULEVARD, SUITE 400, THE WOODLANDS, TX, US",
    "OfficialSite": "https://nkgenbiotech.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "25597700",
    "EBITDA": "-30226000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-2.705",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.42",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-1.069",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "59000",
    "DilutedEPSTTM": "-3.42",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1215.21",
    "PriceToBookRatio": "-",
    "EVToRevenue": "964.78",
    "EVToEBITDA": "-1.129",
    "Beta": "0.475",
    "52WeekHigh": "3.1",
    "52WeekLow": "0.203",
    "50DayMovingAverage": "0.546",
    "200DayMovingAverage": "0.765",
    "SharesOutstanding": "44947600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "RETO": {
    "Symbol": "RETO",
    "AssetType": "Common Stock",
    "Name": "ReTo Eco-Solutions Inc",
    "Description": "ReTo Eco-Solutions, Inc. manufactures and distributes building materials primarily in China. The company is headquartered in Beijing, the People's Republic of China.",
    "CIK": "1687277",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "MANUFACTURING",
    "Industry": "ABRASIVE, ASBESTOS & MISC NONMETALLIC MINERAL PRODS",
    "Address": "C/O BEIJING REIT TECHNOLOGY CO. LTD., 24TH FL., BLDG. B, ANLI RD., CHAOYANG, BEIJING, CHINA",
    "OfficialSite": "https://www.retoeco.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "8261100",
    "EBITDA": "-4335168",
    "PERatio": "0.432",
    "PEGRatio": "None",
    "BookValue": "3.481",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.94",
    "RevenuePerShareTTM": "2.016",
    "ProfitMargin": "-1.328",
    "OperatingMarginTTM": "-0.584",
    "ReturnOnAssetsTTM": "-0.116",
    "ReturnOnEquityTTM": "-0.794",
    "RevenueTTM": "3841100",
    "GrossProfitTTM": "683960",
    "DilutedEPSTTM": "0.94",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.49",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "0.432",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.151",
    "PriceToBookRatio": "0.62",
    "EVToRevenue": "4.119",
    "EVToEBITDA": "-1.277",
    "Beta": "1.381",
    "52WeekHigh": "3.9",
    "52WeekLow": "0.325",
    "50DayMovingAverage": "0.797",
    "200DayMovingAverage": "1.276",
    "SharesOutstanding": "19352600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "AEP": {
    "Symbol": "AEP",
    "AssetType": "Common Stock",
    "Name": "American Electric Power Co Inc",
    "Description": "American Electric Power (AEP) is a major investor-owned electric utility in the United States, delivering electricity to more than five million customers in 11 states.",
    "CIK": "4904",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "ENERGY & TRANSPORTATION",
    "Industry": "ELECTRIC SERVICES",
    "Address": "1 RIVERSIDE PLAZA, COLUMBUS, OH, US",
    "OfficialSite": "https://www.aep.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "56163115000",
    "EBITDA": "7823600000",
    "PERatio": "18.88",
    "PEGRatio": "1.591",
    "BookValue": "50.56",
    "DividendPerShare": "3.57",
    "DividendYield": "0.0353",
    "EPS": "5.58",
    "RevenuePerShareTTM": "37.2",
    "ProfitMargin": "0.15",
    "OperatingMarginTTM": "0.263",
    "ReturnOnAssetsTTM": "0.0286",
    "ReturnOnEquityTTM": "0.114",
    "RevenueTTM": "19721300000",
    "GrossProfitTTM": "9332300000",
    "DilutedEPSTTM": "5.58",
    "QuarterlyEarningsGrowthYOY": "0.97",
    "QuarterlyRevenueGrowthYOY": "0.026",
    "AnalystTargetPrice": "102.13",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "14",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "18.88",
    "ForwardPE": "17.83",
    "PriceToSalesRatioTTM": "2.848",
    "PriceToBookRatio": "2.084",
    "EVToRevenue": "5.15",
    "EVToEBITDA": "12.53",
    "Beta": "0.565",
    "52WeekHigh": "105.73",
    "52WeekLow": "76.22",
    "50DayMovingAverage": "96.39",
    "200DayMovingAverage": "95.86",
    "SharesOutstanding": "533211000",
    "DividendDate": "2025-03-10",
    "ExDividendDate": "2025-02-10"
  },
  "NAAS": {
    "Symbol": "NAAS",
    "AssetType": "Common Stock",
    "Name": "Naas Technology Inc ADR",
    "Description": "None",
    "CIK": "1712178",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TRADE & SERVICES",
    "Industry": "RETAIL-RETAIL STORES, NEC",
    "Address": "NEWLINK CENTER, AREA G, BUILDING 7, HUITONG TIMES SQUARE, CHAOYANG DISTRICT, CHINA",
    "OfficialSite": "https://www.enaas.com/en/",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "22467100",
    "EBITDA": "-685339520",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-16.33",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-9.75",
    "RevenuePerShareTTM": "23.8",
    "ProfitMargin": "-2.855",
    "OperatingMarginTTM": "-1.129",
    "ReturnOnAssetsTTM": "-0.283",
    "ReturnOnEquityTTM": "-19.39",
    "RevenueTTM": "303436000",
    "GrossProfitTTM": "97968000",
    "DilutedEPSTTM": "-9.75",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.551",
    "AnalystTargetPrice": "96",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.074",
    "PriceToBookRatio": "12.36",
    "EVToRevenue": "2.962",
    "EVToEBITDA": "-0.399",
    "Beta": "1.518",
    "52WeekHigh": "34.2",
    "52WeekLow": "1.3",
    "50DayMovingAverage": "1.768",
    "200DayMovingAverage": "4.224",
    "SharesOutstanding": "6645700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "HOLO": {
    "Symbol": "HOLO",
    "AssetType": "Common Stock",
    "Name": "MicroCloud Hologram Inc.",
    "Description": "None",
    "CIK": "1841209",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.",
    "Address": "100 PARK AVENUE, NEW YORK, NY, US",
    "OfficialSite": "https://www.mcholo.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "32254400",
    "EBITDA": "-176474096",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "130.92",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-23.71",
    "RevenuePerShareTTM": "297.87",
    "ProfitMargin": "-0.74",
    "OperatingMarginTTM": "-1.043",
    "ReturnOnAssetsTTM": "-0.217",
    "ReturnOnEquityTTM": "-0.391",
    "RevenueTTM": "234301000",
    "GrossProfitTTM": "47724000",
    "DilutedEPSTTM": "-23.71",
    "QuarterlyEarningsGrowthYOY": "0.299",
    "QuarterlyRevenueGrowthYOY": "0.282",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.138",
    "PriceToBookRatio": "0.325",
    "EVToRevenue": "1.091",
    "EVToEBITDA": "0.844",
    "Beta": "3.583",
    "52WeekHigh": "280",
    "52WeekLow": "1.06",
    "50DayMovingAverage": "1.951",
    "200DayMovingAverage": "10.16",
    "SharesOutstanding": "20544200",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "NVO": {
    "Symbol": "NVO",
    "AssetType": "Common Stock",
    "Name": "Novo Nordisk A/S",
    "Description": "Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.",
    "CIK": "353278",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK",
    "OfficialSite": "https://www.novonordisk.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "369140662000",
    "EBITDA": "146668995000",
    "PERatio": "27.87",
    "PEGRatio": "1.275",
    "BookValue": "32.31",
    "DividendPerShare": "11.4",
    "DividendYield": "0.0183",
    "EPS": "3.16",
    "RevenuePerShareTTM": "65.2",
    "ProfitMargin": "0.348",
    "OperatingMarginTTM": "0.497",
    "ReturnOnAssetsTTM": "0.224",
    "ReturnOnEquityTTM": "0.808",
    "RevenueTTM": "290402992000",
    "GrossProfitTTM": "246842999000",
    "DilutedEPSTTM": "3.16",
    "QuarterlyEarningsGrowthYOY": "0.292",
    "QuarterlyRevenueGrowthYOY": "0.301",
    "AnalystTargetPrice": "110.7",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "27.87",
    "ForwardPE": "23.09",
    "PriceToSalesRatioTTM": "1.271",
    "PriceToBookRatio": "19.51",
    "EVToRevenue": "9.89",
    "EVToEBITDA": "20.91",
    "Beta": "0.192",
    "52WeekHigh": "147.6",
    "52WeekLow": "77.82",
    "50DayMovingAverage": "88.64",
    "200DayMovingAverage": "117.58",
    "SharesOutstanding": "3364180000",
    "DividendDate": "2025-04-08",
    "ExDividendDate": "2025-03-31"
  },
  "MLGO": {
    "Symbol": "MLGO",
    "AssetType": "Common Stock",
    "Name": "MicroAlgo Inc.",
    "Description": "MicroAlgo Inc. develops and delivers central processing algorithm solutions to customers in internet advertisement, gaming, and intelligent chip industries in the People's Republic of China and internationally. The company is headquartered in Shenzhen, the People's Republic of China.",
    "CIK": "1800392",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING SERVICES",
    "Address": "340 MADISON AVENUE,19TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://www.microalgor.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "63427000",
    "EBITDA": "-107966232",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "623.82",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-140.6",
    "RevenuePerShareTTM": "1594.35",
    "ProfitMargin": "-0.354",
    "OperatingMarginTTM": "0.0093",
    "ReturnOnAssetsTTM": "-0.106",
    "ReturnOnEquityTTM": "-0.41",
    "RevenueTTM": "606816000",
    "GrossProfitTTM": "180924000",
    "DilutedEPSTTM": "-140.6",
    "QuarterlyEarningsGrowthYOY": "-0.897",
    "QuarterlyRevenueGrowthYOY": "0.081",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.104",
    "PriceToBookRatio": "0.835",
    "EVToRevenue": "0.235",
    "EVToEBITDA": "2.673",
    "Beta": "2.628",
    "52WeekHigh": "509.6",
    "52WeekLow": "1.11",
    "50DayMovingAverage": "2.088",
    "200DayMovingAverage": "32.03",
    "SharesOutstanding": "9972800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BREA": {
    "Symbol": "BREA",
    "AssetType": "Common Stock",
    "Name": "Brera Holdings PLC Class B Ordinary Shares",
    "Description": "Brera Holdings PLC develops, manages, and operates football clubs. The company is headquartered in Dublin, Ireland.",
    "CIK": "1939965",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-AMUSEMENT & RECREATION SERVICES",
    "Address": "IFSC, 25-28 NORTH WALL QUAY, DUBLIN 1, DUBLIN, IRELAND",
    "OfficialSite": "https://www.breraholdings.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "11969100",
    "EBITDA": "-6412997",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.039",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.5",
    "RevenuePerShareTTM": "0.224",
    "ProfitMargin": "-2.178",
    "OperatingMarginTTM": "-1.964",
    "ReturnOnAssetsTTM": "-0.717",
    "ReturnOnEquityTTM": "-2.498",
    "RevenueTTM": "2680500",
    "GrossProfitTTM": "2444500",
    "DilutedEPSTTM": "-0.5",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "19.4",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "4.465",
    "PriceToBookRatio": "15.39",
    "EVToRevenue": "3.083",
    "EVToEBITDA": "-4.506",
    "Beta": "0.592",
    "52WeekHigh": "2.44",
    "52WeekLow": "0.5",
    "50DayMovingAverage": "0.723",
    "200DayMovingAverage": "0.785",
    "SharesOutstanding": "6625000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "CDT": {
    "Symbol": "CDT",
    "AssetType": "Common Stock",
    "Name": "Conduit Pharmaceuticals Inc.",
    "Description": "None",
    "CIK": "1896212",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "4995 MURPHY CANYON ROAD, SUITE 300, SAN DIEGO, CA, UNITED STATES",
    "OfficialSite": "https://www.conduitpharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "4188600",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-9.5",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-23",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-1.088",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-23",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-55.41",
    "Beta": "2.159",
    "52WeekHigh": "392",
    "52WeekLow": "1.09",
    "50DayMovingAverage": "5.43",
    "200DayMovingAverage": "58.32",
    "SharesOutstanding": "3642300",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MFI": {
    "Symbol": "MFI",
    "AssetType": "Common Stock",
    "Name": "mF International Limited Ordinary Shares",
    "Description": "None",
    "CIK": "1940941",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING SERVICES",
    "Address": "UNIT 1801, FORTIS TOWER, 77-79 GLOUCESTER ROAD, WAN CHAI, HK",
    "OfficialSite": "https://www.m-finance.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "8348600",
    "EBITDA": "-2127358",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.817",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.02",
    "RevenuePerShareTTM": "2.546",
    "ProfitMargin": "-0.0376",
    "OperatingMarginTTM": "-0.507",
    "ReturnOnAssetsTTM": "-0.0265",
    "ReturnOnEquityTTM": "-0.0375",
    "RevenueTTM": "30278500",
    "GrossProfitTTM": "15994700",
    "DilutedEPSTTM": "-0.02",
    "QuarterlyEarningsGrowthYOY": "1.179",
    "QuarterlyRevenueGrowthYOY": "-0.119",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.276",
    "PriceToBookRatio": "1.284",
    "EVToRevenue": "1.466",
    "EVToEBITDA": "9.33",
    "Beta": "None",
    "52WeekHigh": "14.49",
    "52WeekLow": "0.506",
    "50DayMovingAverage": "0.737",
    "200DayMovingAverage": "0.829",
    "SharesOutstanding": "13251700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SOPA": {
    "Symbol": "SOPA",
    "AssetType": "Common Stock",
    "Name": "Society Pass Inc",
    "Description": "Society Pass Incorporated is dedicated to the acquisition and operation of e-commerce platforms for consumers and merchants in Southeast Asia. The company is headquartered in Carson City, Nevada.",
    "CIK": "1817511",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-BUSINESS SERVICES, NEC",
    "Address": "30 GONDOLIERS BLUFF, NEWPORT COAST, CA, US",
    "OfficialSite": "https://thesocietypass.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5869600",
    "EBITDA": "-10511758",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.24",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-5",
    "RevenuePerShareTTM": "2.671",
    "ProfitMargin": "-1.711",
    "OperatingMarginTTM": "-0.701",
    "ReturnOnAssetsTTM": "-0.37",
    "ReturnOnEquityTTM": "-2.218",
    "RevenueTTM": "6906200",
    "GrossProfitTTM": "1966600",
    "DilutedEPSTTM": "-5",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.261",
    "AnalystTargetPrice": "16",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.85",
    "PriceToBookRatio": "7.4",
    "EVToRevenue": "0.507",
    "EVToEBITDA": "-0.0879",
    "Beta": "1.342",
    "52WeekHigh": "6.75",
    "52WeekLow": "0.727",
    "50DayMovingAverage": "1.511",
    "200DayMovingAverage": "1.299",
    "SharesOutstanding": "3645700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MBRX": {
    "Symbol": "MBRX",
    "AssetType": "Common Stock",
    "Name": "Moleculin Biotech Inc",
    "Description": "Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant viruses and tumors in the United States. The company is headquartered in Houston, Texas.",
    "CIK": "1659617",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, US",
    "OfficialSite": "https://moleculin.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "4446800",
    "EBITDA": "-28787000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "2.491",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-12.04",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.575",
    "ReturnOnEquityTTM": "-1.415",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-12.04",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "28",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.711",
    "EVToRevenue": "-",
    "EVToEBITDA": "0.523",
    "Beta": "1.935",
    "52WeekHigh": "10.35",
    "52WeekLow": "0.398",
    "50DayMovingAverage": "1.667",
    "200DayMovingAverage": "2.802",
    "SharesOutstanding": "4155900",
    "DividendDate": "2021-02-01",
    "ExDividendDate": "None"
  },
  "WAFU": {
    "Symbol": "WAFU",
    "AssetType": "Common Stock",
    "Name": "Wah Fu Education Group Ltd",
    "Description": "Wah Fu Education Group Limited, provides online exam preparation services and related technology solutions in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.",
    "CIK": "1716770",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-EDUCATIONAL SERVICES",
    "Address": "RM 505 BLDG NO. 40, NO. 1 DISHENG N ST, ECONOMIC & TECHNOLOGICAL DEVELOP. ZONE, BEIJING, CHINA",
    "OfficialSite": "https://www.edu-edu.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "8071800",
    "EBITDA": "-116491",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "2.528",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.01",
    "RevenuePerShareTTM": "1.631",
    "ProfitMargin": "-0.0077",
    "OperatingMarginTTM": "-0.144",
    "ReturnOnAssetsTTM": "-0.0089",
    "ReturnOnEquityTTM": "-0.0299",
    "RevenueTTM": "7223200",
    "GrossProfitTTM": "3023500",
    "DilutedEPSTTM": "-0.01",
    "QuarterlyEarningsGrowthYOY": "-0.737",
    "QuarterlyRevenueGrowthYOY": "-0.318",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.117",
    "PriceToBookRatio": "0.724",
    "EVToRevenue": "0.063",
    "EVToEBITDA": "-1.558",
    "Beta": "0.96",
    "52WeekHigh": "2.63",
    "52WeekLow": "1.46",
    "50DayMovingAverage": "1.705",
    "200DayMovingAverage": "1.808",
    "SharesOutstanding": "4410600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SLXN": {
    "Symbol": "SLXN",
    "AssetType": "Common Stock",
    "Name": "Biomotion Sciences Ordinary Shares",
    "Description": "None",
    "CIK": "2022416",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "12 ABBA HILLEL ROAD, RAMAT-GAN, IL",
    "OfficialSite": "https://silexion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "9866100",
    "EBITDA": "-1355000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "4.669",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.66",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.621",
    "ReturnOnEquityTTM": "-1.167",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-0.66",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "13.56",
    "52WeekLow": "0.207",
    "50DayMovingAverage": "7.62",
    "200DayMovingAverage": "10.27",
    "SharesOutstanding": "9768400",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PITA": {
    "Symbol": "PITA",
    "AssetType": "Common Stock",
    "Name": "Heramba Electric plc Ordinary Shares",
    "Description": "None",
    "CIK": "None",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "None",
    "FiscalYearEnd": "None",
    "LatestQuarter": "None",
    "MarketCapitalization": "None",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "None",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "15",
    "52WeekLow": "0.343",
    "50DayMovingAverage": "0",
    "200DayMovingAverage": "0",
    "SharesOutstanding": "0",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GTBP": {
    "Symbol": "GTBP",
    "AssetType": "Common Stock",
    "Name": "GT Biopharma Inc",
    "Description": "GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its patented immune-enhancer cell fusion protein Tri-specific Killer Engager (TriKE) technology platform. The company is headquartered in Beverly Hills, California.",
    "CIK": "109657",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1825 K STREET, SUITE 510, WASHINGTON, D.C., DC, US",
    "OfficialSite": "https://www.gtbiopharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "6233800",
    "EBITDA": "-6760000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "5.41",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-7.39",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.606",
    "ReturnOnEquityTTM": "-1.315",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-7.39",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "11",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "2.164",
    "EVToRevenue": "-",
    "EVToEBITDA": "-0.0876",
    "Beta": "0.57",
    "52WeekHigh": "10.66",
    "52WeekLow": "1.72",
    "50DayMovingAverage": "2.625",
    "200DayMovingAverage": "3.128",
    "SharesOutstanding": "2234300",
    "DividendDate": "2017-08-21",
    "ExDividendDate": "None"
  },
  "ENVB": {
    "Symbol": "ENVB",
    "AssetType": "Common Stock",
    "Name": "Enveric Biosciences Inc",
    "Description": "Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.",
    "CIK": "890821",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SEMICONDUCTORS & RELATED DEVICES",
    "Address": "2025 GATEWAY PLACE, SUITE 365, SAN JOSE, CA, US",
    "OfficialSite": "https://www.enveric.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2633000",
    "EBITDA": "-8503116",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.59",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-36.3",
    "RevenuePerShareTTM": "37.68",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.969",
    "ReturnOnEquityTTM": "-3.086",
    "RevenueTTM": "35405100",
    "GrossProfitTTM": "8150700",
    "DilutedEPSTTM": "-36.3",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.073",
    "AnalystTargetPrice": "8.32",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "23.09",
    "PriceToSalesRatioTTM": "0.0831",
    "PriceToBookRatio": "0.669",
    "EVToRevenue": "1.758",
    "EVToEBITDA": "0.289",
    "Beta": "0.191",
    "52WeekHigh": "43.8",
    "52WeekLow": "1.13",
    "50DayMovingAverage": "50.87",
    "200DayMovingAverage": "105.44",
    "SharesOutstanding": "1921900",
    "DividendDate": "2019-11-25",
    "ExDividendDate": "2008-04-23"
  },
  "ONVO": {
    "Symbol": "ONVO",
    "AssetType": "Common Stock",
    "Name": "Organovo Holdings Inc",
    "Description": "Organovo Holdings, Inc., a biotechnology company, is focused on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in Solana Beach, California.",
    "CIK": "1497253",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO, CA, US",
    "OfficialSite": "https://www.organovo.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "22167200",
    "EBITDA": "-12282000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.021",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.84",
    "RevenuePerShareTTM": "0.008",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-144.5",
    "ReturnOnAssetsTTM": "-1.234",
    "ReturnOnEquityTTM": "-3.784",
    "RevenueTTM": "122000",
    "GrossProfitTTM": "-5112000",
    "DilutedEPSTTM": "-0.84",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "3.8",
    "AnalystTargetPrice": "5.4",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "181.7",
    "PriceToBookRatio": "17.69",
    "EVToRevenue": "51.96",
    "EVToEBITDA": "-0.336",
    "Beta": "0.532",
    "52WeekHigh": "1.83",
    "52WeekLow": "0.315",
    "50DayMovingAverage": "0.377",
    "200DayMovingAverage": "0.56",
    "SharesOutstanding": "17454500",
    "DividendDate": "2020-08-19",
    "ExDividendDate": "None"
  },
  "DOMH": {
    "Symbol": "DOMH",
    "AssetType": "Common Stock",
    "Name": "Dominari Holdings Inc.",
    "Description": "None",
    "CIK": "12239",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "PATENT OWNERS & LESSORS",
    "Address": "ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://www.dominariholdings.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "108040000",
    "EBITDA": "-14179000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.1",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "-3.86",
    "RevenuePerShareTTM": "2.113",
    "ProfitMargin": "-1.802",
    "OperatingMarginTTM": "-0.79",
    "ReturnOnAssetsTTM": "-0.425",
    "ReturnOnEquityTTM": "-0.47",
    "RevenueTTM": "12589000",
    "GrossProfitTTM": "12589000",
    "DilutedEPSTTM": "-3.86",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "3.198",
    "AnalystTargetPrice": "16",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "8.58",
    "PriceToBookRatio": "2.127",
    "EVToRevenue": "6.15",
    "EVToEBITDA": "1.696",
    "Beta": "1.266",
    "52WeekHigh": "13.05",
    "52WeekLow": "0.794",
    "50DayMovingAverage": "3.205",
    "200DayMovingAverage": "2.184",
    "SharesOutstanding": "10913100",
    "DividendDate": "2025-03-03",
    "ExDividendDate": "2025-02-24"
  },
  "JTAI": {
    "Symbol": "JTAI",
    "AssetType": "Common Stock",
    "Name": "Jet.AI Inc.",
    "Description": "Jet. The company is headquartered in Las Vegas, Nevada.",
    "CIK": "1861622",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "SUITE 201, 42 EDWARD STREET, GEORGE TOWN, GRAND CAYMAN, KY",
    "OfficialSite": "https://jet.ai",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "11336300",
    "EBITDA": "-12325496",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-33.78",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-191.17",
    "RevenuePerShareTTM": "234.42",
    "ProfitMargin": "-0.831",
    "OperatingMarginTTM": "-0.736",
    "ReturnOnAssetsTTM": "-1.898",
    "ReturnOnEquityTTM": "-31.99",
    "RevenueTTM": "15028900",
    "GrossProfitTTM": "-628371",
    "DilutedEPSTTM": "-191.17",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.163",
    "AnalystTargetPrice": "20",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.754",
    "PriceToBookRatio": "-",
    "EVToRevenue": "0.896",
    "EVToEBITDA": "-0.73",
    "Beta": "-0.076",
    "52WeekHigh": "315",
    "52WeekLow": "2.3",
    "50DayMovingAverage": "4.033",
    "200DayMovingAverage": "45.93",
    "SharesOutstanding": "1927900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  }
}
